Ratings Moves: ING,...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.50 -0.07 | -2.72%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -32.28M | -32.45M | -27.49M | -23.22M |
| Operating Gains/Losses | 165.00K | 209.00K | 151.00K | 44.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -1.81M | -670.00K | -902.00K | -986.00K |
| (Increase) Decrease in Inventories | 143.00K | 60.00K | -777.00K | -446.00K |
| (Increase) Decrease In Other Current Assets | -324.00K | -3.00K | 36.00K | 41.00K |
| (Decrease) Increase In Payables | 1.18M | -1.44M | 811.00K | 413.00K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -5.31M | -2.78M | 707.00K | -8.99M |
| Other Non-Cash Items | 4.18M | 179.00K | 2.26M | 6.94M |
| Net Cash From Continuing Operations | -32.19M | -35.32M | -23.57M | -23.81M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -32.19M | -35.32M | -23.57M | -23.81M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.20M | -560.00K | -610.00K | -221.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | -350.00K | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.20M | -560.00K | -1.29M | -221.00K |
| Issuance of Debt | 0.00 | 9.44M | 20.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 26.37M | 16.14M | 52.61M | 27.66M |
| Repayment of Long-Term Debt | -2.69M | -4.53M | -5.45M | -2.05M |
| Repurchase of Capital Stock | -1.48M | -194.00K | -1.92M | -1.34M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -719.00K | -559.00K | 0.00 |
| Net Cash From Financing Activities | 22.19M | 20.14M | 64.68M | 24.27M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -11.20M | -15.75M | 39.81M | 243.00K |
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserMy SP portfolio
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
Latest CYTX Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- Stocks Socked Despite Upbeat China Numbers; Apple Falls 12.14.12 | 04:12 pm
- 5 Stocks Under $10 Set to Soar 10.11.12 | 01:10 pm
- 5 Biotech Stocks Under $10 Blasting Higher 08.14.12 | 03:08 pm
- 5 Biotech Stocks Under $5 Making Bullish Moves 06.21.12 | 01:06 pm
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
Press Releases for CYTX
- Cytori Patents Method Of Treating Renal Diseases Using Adipose-Derived Regenerative Cells - Business Wire 03.28.13 | 08:03 am
- Cytori Provides Update In 510(k) Appeal Decision - Business Wire 03.22.13 | 02:03 pm
- Cytori Therapeutics To Present At The 25th Annual Roth Conference On March 18 - Business Wire 03.11.13 | 08:03 am
- Cytori Reports 2012 Business And Financial Results; Provides Outlook For 2013 - Business Wire 03.07.13 | 04:03 pm
- Cytori To Webcast Fourth Quarter And Year End Financial Results On March 7 - Business Wire 02.28.13 | 08:02 am
- Cytori Appoints Dr. Steven Kesten As Executive Vice President And Chief Medical Officer - Business Wire 02.26.13 | 08:02 am
- Intravase® Approval Opens Vascular Market For Cytori - Business Wire 02.25.13 | 09:02 am
- Cytori Announces Presentation At Biotech Showcase™ On January 8th - Business Wire 01.04.13 | 08:01 am
- Cytori Therapeutics Prices $20.0 Million Public Offering Of Common Stock - Business Wire 12.14.12 | 09:12 am
- Cytori Therapeutics Proposes Public Offering Of Common Stock - Business Wire 12.13.12 | 04:12 pm
Partner Headlines for CYTX
- With Cytori Therapeutics, The Waiting Is The Hardest Part - Seeking Alpha 08.14.12 | 09:08 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
